Sanofi SA at TD Cowen Health Care Conference Transcript
Well, Good afternoon. We're delighted to have Sanofi with us at Cowen's 44th Annual Healthcare Conference, representing the company is Naimish Patel, who is Global Head of Development for immunology and inflammation and Erik Wallström, who is Global Head of Development for Neurology. There's so much going on in these areas. So we have a lot to cover, and we're going to jump right in.
Questions & Answers
So let's start out with the immunology and inflammation area. Dupixent is a phenomenal drug. So what unmet need in patient subgroups either for asthma or atopic dermatitis are not well served today that still represent opportunity for Sanofi?
Sure. Thanks, Steve. Happy to be here today. I can start with atopic dermatitis. Its a huge disease
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
